Thisara Jayawickrama Withanage, Ron Alcalay, Olga Krichevsky, Ellen Wachtel, Ohad Mazor, Guy Patchornik
{"title":"一种含[嗜绿碱:金属]配合物的fc融合蛋白的纯化。","authors":"Thisara Jayawickrama Withanage, Ron Alcalay, Olga Krichevsky, Ellen Wachtel, Ohad Mazor, Guy Patchornik","doi":"10.3390/antib14010011","DOIUrl":null,"url":null,"abstract":"<p><p>In this study, we assess an alternative Fc-fusion protein purification method that does not rely on chromatographic media or ligands. Recombinant human acetylcholinesterase, fused to the Fc domain of human IgG1 (henceforth, AChE-Fc), was purified with precipitated aromatic complexes composed of the bathophenanthroline (henceforth, batho) chelator with either Zn<sup>2+</sup> or Cu<sup>2+</sup> ions (i.e., [(batho)<sub>3</sub>:Zn<sup>2+</sup>] or [(batho)<sub>2</sub>:Cu<sup>2+</sup>]) in the presence of polyethylene glycol 6000 (PEG-6000). In a three-step purification process conducted at pH 7, AChE-Fc was captured by the aromatic complexes (Step 1); unbound or weakly bound protein impurities were removed with 20 mM NaCl (Step 2); and AChE-Fc was then extracted at pH 7 (Step 3) using 100 mM Na citrate buffer in 250 mM NaCl. Purified AChE-Fc was not aggregated (as determined by dynamic light scattering (DLS) and Native PAGE). However, full enzymatic activity was only preserved with the [(batho)<sub>3</sub>:Zn<sup>2+</sup>] complex. Interaction between AChE-Fc and [(batho)<sub>3</sub>:Zn<sup>2+</sup>] led to ~83-88% overall protein yield. Thirty-fold process upscaling by volume required only proportional increase in the amounts of [(batho)<sub>3</sub>:Zn<sup>2+</sup>] and PEG-6000. Efficient (95-97%) chelator recycling was achieved by recrystallization. Chelator leaching into purified AchE-Fc was estimated to be ~0.3% relative to the total amount used. Taken together, this novel procedure has the potential to provide an economical and practical avenue for the industrial purification of Fc-fusion proteins.</p>","PeriodicalId":8188,"journal":{"name":"Antibodies","volume":"14 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843901/pdf/","citationCount":"0","resultStr":"{\"title\":\"Purification of a Fc-Fusion Protein with [Bathophenathroline:metal] Complexes.\",\"authors\":\"Thisara Jayawickrama Withanage, Ron Alcalay, Olga Krichevsky, Ellen Wachtel, Ohad Mazor, Guy Patchornik\",\"doi\":\"10.3390/antib14010011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this study, we assess an alternative Fc-fusion protein purification method that does not rely on chromatographic media or ligands. Recombinant human acetylcholinesterase, fused to the Fc domain of human IgG1 (henceforth, AChE-Fc), was purified with precipitated aromatic complexes composed of the bathophenanthroline (henceforth, batho) chelator with either Zn<sup>2+</sup> or Cu<sup>2+</sup> ions (i.e., [(batho)<sub>3</sub>:Zn<sup>2+</sup>] or [(batho)<sub>2</sub>:Cu<sup>2+</sup>]) in the presence of polyethylene glycol 6000 (PEG-6000). In a three-step purification process conducted at pH 7, AChE-Fc was captured by the aromatic complexes (Step 1); unbound or weakly bound protein impurities were removed with 20 mM NaCl (Step 2); and AChE-Fc was then extracted at pH 7 (Step 3) using 100 mM Na citrate buffer in 250 mM NaCl. Purified AChE-Fc was not aggregated (as determined by dynamic light scattering (DLS) and Native PAGE). However, full enzymatic activity was only preserved with the [(batho)<sub>3</sub>:Zn<sup>2+</sup>] complex. Interaction between AChE-Fc and [(batho)<sub>3</sub>:Zn<sup>2+</sup>] led to ~83-88% overall protein yield. Thirty-fold process upscaling by volume required only proportional increase in the amounts of [(batho)<sub>3</sub>:Zn<sup>2+</sup>] and PEG-6000. Efficient (95-97%) chelator recycling was achieved by recrystallization. Chelator leaching into purified AchE-Fc was estimated to be ~0.3% relative to the total amount used. Taken together, this novel procedure has the potential to provide an economical and practical avenue for the industrial purification of Fc-fusion proteins.</p>\",\"PeriodicalId\":8188,\"journal\":{\"name\":\"Antibodies\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843901/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antibodies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/antib14010011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/antib14010011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
本研究评估了一种不依赖色谱介质或配体的 Fc 融合蛋白纯化替代方法。与人 IgG1 的 Fc 结构域融合的重组人乙酰胆碱酯酶(以下简称 AChE-Fc)用由浴菲罗啉(以下简称浴)螯合剂与 Zn2+ 或 Cu2+ 离子(即[(浴)3:Zn2+]或[(浴)2:Cu2+])组成的沉淀芳香复合物纯化、(batho)3:Zn2+]或[(batho)2:Cu2+])组成的芳香络合物。在 pH 值为 7 的三步纯化过程中,芳香族复合物捕获 AChE-Fc(步骤 1);用 20 mM NaCl 去除未结合或弱结合的蛋白质杂质(步骤 2);然后在 pH 值为 7 的条件下,用 100 mM 柠檬酸纳缓冲液和 250 mM NaCl 提取 AChE-Fc(步骤 3)。纯化的 AChE-Fc 没有聚集(由动态光散射(DLS)和 Native PAGE 确定)。然而,只有在[(batho)3:Zn2+]复合物中才能保持完整的酶活性。AChE-Fc 与[(batho)3:Zn2+]之间的相互作用使蛋白质的总产率达到约 83-88%。按体积将工艺放大 30 倍,只需按比例增加 [(batho)3:Zn2+] 和 PEG-6000 的用量。通过重结晶,实现了螯合剂的有效回收(95-97%)。据估计,纯化的 AchE-Fc 中螯合剂的浸出率约为所用总量的 0.3%。综上所述,这种新型程序有望为 Fc 融合蛋白的工业纯化提供一条经济实用的途径。
Purification of a Fc-Fusion Protein with [Bathophenathroline:metal] Complexes.
In this study, we assess an alternative Fc-fusion protein purification method that does not rely on chromatographic media or ligands. Recombinant human acetylcholinesterase, fused to the Fc domain of human IgG1 (henceforth, AChE-Fc), was purified with precipitated aromatic complexes composed of the bathophenanthroline (henceforth, batho) chelator with either Zn2+ or Cu2+ ions (i.e., [(batho)3:Zn2+] or [(batho)2:Cu2+]) in the presence of polyethylene glycol 6000 (PEG-6000). In a three-step purification process conducted at pH 7, AChE-Fc was captured by the aromatic complexes (Step 1); unbound or weakly bound protein impurities were removed with 20 mM NaCl (Step 2); and AChE-Fc was then extracted at pH 7 (Step 3) using 100 mM Na citrate buffer in 250 mM NaCl. Purified AChE-Fc was not aggregated (as determined by dynamic light scattering (DLS) and Native PAGE). However, full enzymatic activity was only preserved with the [(batho)3:Zn2+] complex. Interaction between AChE-Fc and [(batho)3:Zn2+] led to ~83-88% overall protein yield. Thirty-fold process upscaling by volume required only proportional increase in the amounts of [(batho)3:Zn2+] and PEG-6000. Efficient (95-97%) chelator recycling was achieved by recrystallization. Chelator leaching into purified AchE-Fc was estimated to be ~0.3% relative to the total amount used. Taken together, this novel procedure has the potential to provide an economical and practical avenue for the industrial purification of Fc-fusion proteins.
期刊介绍:
Antibodies (ISSN 2073-4468), an international, peer-reviewed open access journal which provides an advanced forum for studies related to antibodies and antigens. It publishes reviews, research articles, communications and short notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. Full experimental and/or methodical details must be provided. Electronic files or software regarding the full details of the calculation and experimental procedure - if unable to be published in a normal way - can be deposited as supplementary material. This journal covers all topics related to antibodies and antigens, topics of interest include (but are not limited to): antibody-producing cells (including B cells), antibody structure and function, antibody-antigen interactions, Fc receptors, antibody manufacturing antibody engineering, antibody therapy, immunoassays, antibody diagnosis, tissue antigens, exogenous antigens, endogenous antigens, autoantigens, monoclonal antibodies, natural antibodies, humoral immune responses, immunoregulatory molecules.